Literature DB >> 21289665

Corynebacterium vaginale: a neglected pathogen in family practice.

H P Batty.   

Abstract

In an urban practice, 76 cases of Corynebacterium vaginale infection were discovered in a two year period. In retrospect, eight percent of the female patients in the practice had this organism. Most of these women were symptomatic and 45% had atypical Pap smears. Sulfa vaginal cream was found to be ineffective in six of nine cases. Various oral antibiotic treatments of both partners were compared. A ten day course of metronidazole was found to give the best result. Metronidazole in one dose, ampicillin and tetracycline were found to be less effective.

Entities:  

Year:  1981        PMID: 21289665      PMCID: PMC2305814     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  Corynebacterium genitalium (nonspecific urethritis corynebacteria). Biologic reactions differentiating commensals of the urogenital tract from the pathogens responsible for urethritis.

Authors:  G Furness; A T Evangelista; Z Kaminski
Journal:  Invest Urol       Date:  1977-07

2.  Neonatal Hemophilus vaginalis (Corynebacterium vaginalis) infection.

Authors:  M S Platt
Journal:  Clin Pediatr (Phila)       Date:  1971-09       Impact factor: 1.168

3.  Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole.

Authors:  T A Pheifer; P S Forsyth; M A Durfee; H M Pollock; K K Holmes
Journal:  N Engl J Med       Date:  1978-06-29       Impact factor: 91.245

4.  Corynebacterium vaginale (Hemophilus vaginalis) bacteremia: clinical study of 29 cases.

Authors:  T K Venkataramani; H K Rathbun
Journal:  Johns Hopkins Med J       Date:  1976-09

Review 5.  Corynebacterium vaginale.

Authors:  W E Dunkelberg
Journal:  Sex Transm Dis       Date:  1977 Apr-Jun       Impact factor: 2.830

6.  Hemophilus vaginalis bacteremia.

Authors:  C Adeniyi-Jones; D J Groves; A Mannethu; J Righter
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.